Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

Turning a 10-Year Vision into a 10-Year Plan

Business Services, Market Access, Market Access Consultancy | Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …

Feature

Uterine fibroids and the cost of silence

Medical Communications, Research and Development | Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …

Feature

Novel excipients: the key to unlocking drug innovation

Business Services | Lubrizol, Pharmacy

ADVERTORIAL, IN ASSOCIATION WITH LUBRIZOL Meera Raghuram, Director of Regulatory and Sustainability Strategy at Lubrizol, explores how formulators can overcome …

Feature
Thought Leadership

The Pharma Files: With Colin Williams from Astellas Pharma

Medical Communications, Research and Development | Astellas Pharma, Corporate, The Pharma Files, pm society

Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …

Feature

How can optichannel engagement drive return on investment across the product life cycle?

Business Services, Consultancy | Corporate, PharmaForceIQ, Pharmacy, chief strategy officer, optichannel engagement

HCPs and patients are demanding personalised, streamlined experiences. Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ, discusses how optichannel engagement offers a …

Feature

Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness

Medical Communications, Research and Development | Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

From sickness to prevention: the case for population health management

Business Services, Market Access, Market Access Consultancy | Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

Feature

From Vaccine Innovation Pathway to growth powerhouse: how the UK is transforming clinical trials

Business Services, Market Access, Market Access Consultancy, Sales and Marketing | 10 Year Health Plan, Life Sciences Sector Plan, NHS, National Institute for Health and Care Research, Pharmacy, UK Vaccine Innovation Pathway

Commercial clinical trials are a high-value growth driver for a country’s health and the economy and a key component of …

Feature
Thought Leadership

Five Facts about Breast Cancer

Medical Communications | Breast Cancer Awareness Month, Five Facts, Oncology, breast cancer

1 There are striking inequities in breast cancer burden regarding the Human Development Index (HDI), the United Nation’s measure of …

Feature

Unlocking nature’s pharmacy: how tea leaves and marine organisms could help transform breast cancer treatment

Research and Development | King Abdullah University of Science and Technology, Oncology, natural products chemistry, triple-negative breast cancer

Looking beyond synthetic chemistry to unlock powerful, naturally derived medicines Each year, World Breast Cancer Awareness Month serves as a …

Feature

Combination treatments: Takeda’s Implementation Framework and the broader landscape

Research and Development | HIV/AIDS, Hepatology, NHS, NICE, Oncology, Takeda, combination therapy, oncology

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …

Feature

Rare and severe epilepsies – current treatments and advance therapeutics

Medical Communications, Research and Development | Neurology, UCB, epilepsy, epilepsy treatment, rare epilepsies

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature
hospital

The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex

Medical Communications, Research and Development | Corporate, GP, Health Innovation Kent Surrey Sussex, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …

Feature

How pharma marketing needs to adapt as community pharmacies take centre stage

Business Services, Medical Communications, Sales and Marketing | 10 Year Health Plan, Pharmacy, m3, pharmacy

The UK government’s 10-Year Health Plan is moving pharmacists to the frontline of primary care For decades, community pharmacies were …

Feature

The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?

Business Services, Market Access, Market Access Consultancy, Sales and Marketing | NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

Feature
Thought Leadership
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026